Post-Authorization Safety Study to Assess the Effectiveness of the Newly Implemented Risk Minimization Measures for Topiramate: HCP and Patient Knowledge and Behavior Survey

ENCePP Code of conduct

Yes

Data sources

• Data source(s), other:
  The data source will be on-line questionnaires completed by HCPs and patients (or parents/caregivers) who have passed the screening and who have given consent.
• Data sources (types):
  Other

  Patient surveys
• Data sources (types), other:
  Surveys from HCPs including general practitioners (GPs), specialists in internal medicine, other specialists managing epilepsy and/or migraine (including neurologists, general pediatricians, neuro-pediatricians), obstetricians/gynecologists (OB/GYN), midwives, and pharmacists

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown